Medical Devices & Consumables
Global Mammalian Cell Banking Market Research Report 2025
- Jan 09, 25
- ID: 797312
- Pages: 89
- Figures: 89
- Views: 1
The global market for Mammalian Cell Banking was valued at US$ 2130 million in the year 2024 and is projected to reach a revised size of US$ 3837 million by 2031, growing at a CAGR of 8.9% during the forecast period.
Mammalian Cells are regularly used in the biopharmaceutical industry for the production of recombinant therapeutic proteins. Moreover, mammalian cell lines are used as host cells for the production of biologics in the biopharmaceutical industry.
The global mammalian cell banking market refers to the market for the storage and preservation of mammalian cells for research, therapeutics, and bioproduction purposes. Mammalian cell banking involves the cryopreservation of cell lines or primary cells for long-term storage, ensuring their viability and functionality.
Here are the key factors influencing the growth of the global mammalian cell banking market:
Biopharmaceutical research and development: The biopharmaceutical industry extensively utilizes mammalian cell banking for the development of novel drugs and biologics. Mammalian cells, such as Chinese hamster ovary (CHO) cells, are commonly used for the production of recombinant proteins, monoclonal antibodies, and vaccines. With the increasing focus on personalized medicine and biologics, the demand for mammalian cell banking in biopharmaceutical research and development is rising.
Cell-based therapies: Mammalian cell banking plays a crucial role in cell-based therapies, such as regenerative medicine, gene therapy, and immunotherapy. The cryopreserved mammalian cells can be used as starting materials for the production of cell-based therapies, enabling consistent product quality and reducing manufacturing time. As the field of cell-based therapies continues to advance and gain regulatory approval, the demand for mammalian cell banking is expected to grow.
Increased adoption of in vitro models: Mammalian cell banking is essential for the creation and maintenance of in vitro cell models used in various fields, including drug discovery, toxicology studies, and disease modeling. In vitro models provide a cost-effective and ethical alternative to animal testing and allow for more accurate prediction of human responses. The growing adoption of in vitro models by pharmaceutical companies, research institutions, and regulatory agencies is driving the demand for mammalian cell banking.
Advancements in bioproduction techniques: The development of advanced bioproduction technologies, such as bioreactors and single-use systems, has increased the efficiency and scalability of mammalian cell culture processes. Mammalian cell banks serve as a source of starting materials for large-scale production, ensuring consistent cell quality and reducing the risk of contamination. The continuous improvement in bioproduction techniques is fueling the growth of the mammalian cell banking market.
Emerging applications in bioengineering and synthetic biology: Mammalian cell banking is finding new applications in the fields of bioengineering and synthetic biology. These fields involve the genetic modification and engineering of mammalian cells for various purposes, such as the production of biofuels, industrial enzymes, and biomaterials. Mammalian cell banks provide a renewable source of engineered cells, enabling researchers and companies to explore novel applications in these emerging fields.
In summary, the global mammalian cell banking market is driven by factors such as the increasing demand for biopharmaceuticals, the growth of cell-based therapies, the adoption of in vitro models, advancements in bioproduction techniques, and emerging applications in bioengineering and synthetic biology. As the biopharmaceutical industry and cell-based therapies continue to expand, the global mammalian cell banking market is expected to experience significant growth in the coming years.
This report aims to provide a comprehensive presentation of the global market for Mammalian Cell Banking, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mammalian Cell Banking.
The Mammalian Cell Banking market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Mammalian Cell Banking market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mammalian Cell Banking companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sartorius Stedim BioOutsource Limited.
Charles River Laboratories.
Eurofins DiscoverX Corporation
Merck KGaA
Lonza Group Ltd
ViruSure
Altogen Labs
Abzena Ltd
Northway Biotechpharma
Selexis SA
Thermo Fisher Scientific Inc.
Catalent, Inc.
CellBank Australia
Creative Bioarray
GenScript Biotech Corporation
Segment by Type
CHO Cell
Human Cells
Animal Cells
Others
Segment by Application
Academic & Research Laboratories
Biopharmaceutical Companies
Contract Research Organizations (CROs)
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Mammalian Cell Banking company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Mammalian Cells are regularly used in the biopharmaceutical industry for the production of recombinant therapeutic proteins. Moreover, mammalian cell lines are used as host cells for the production of biologics in the biopharmaceutical industry.
The global mammalian cell banking market refers to the market for the storage and preservation of mammalian cells for research, therapeutics, and bioproduction purposes. Mammalian cell banking involves the cryopreservation of cell lines or primary cells for long-term storage, ensuring their viability and functionality.
Here are the key factors influencing the growth of the global mammalian cell banking market:
Biopharmaceutical research and development: The biopharmaceutical industry extensively utilizes mammalian cell banking for the development of novel drugs and biologics. Mammalian cells, such as Chinese hamster ovary (CHO) cells, are commonly used for the production of recombinant proteins, monoclonal antibodies, and vaccines. With the increasing focus on personalized medicine and biologics, the demand for mammalian cell banking in biopharmaceutical research and development is rising.
Cell-based therapies: Mammalian cell banking plays a crucial role in cell-based therapies, such as regenerative medicine, gene therapy, and immunotherapy. The cryopreserved mammalian cells can be used as starting materials for the production of cell-based therapies, enabling consistent product quality and reducing manufacturing time. As the field of cell-based therapies continues to advance and gain regulatory approval, the demand for mammalian cell banking is expected to grow.
Increased adoption of in vitro models: Mammalian cell banking is essential for the creation and maintenance of in vitro cell models used in various fields, including drug discovery, toxicology studies, and disease modeling. In vitro models provide a cost-effective and ethical alternative to animal testing and allow for more accurate prediction of human responses. The growing adoption of in vitro models by pharmaceutical companies, research institutions, and regulatory agencies is driving the demand for mammalian cell banking.
Advancements in bioproduction techniques: The development of advanced bioproduction technologies, such as bioreactors and single-use systems, has increased the efficiency and scalability of mammalian cell culture processes. Mammalian cell banks serve as a source of starting materials for large-scale production, ensuring consistent cell quality and reducing the risk of contamination. The continuous improvement in bioproduction techniques is fueling the growth of the mammalian cell banking market.
Emerging applications in bioengineering and synthetic biology: Mammalian cell banking is finding new applications in the fields of bioengineering and synthetic biology. These fields involve the genetic modification and engineering of mammalian cells for various purposes, such as the production of biofuels, industrial enzymes, and biomaterials. Mammalian cell banks provide a renewable source of engineered cells, enabling researchers and companies to explore novel applications in these emerging fields.
In summary, the global mammalian cell banking market is driven by factors such as the increasing demand for biopharmaceuticals, the growth of cell-based therapies, the adoption of in vitro models, advancements in bioproduction techniques, and emerging applications in bioengineering and synthetic biology. As the biopharmaceutical industry and cell-based therapies continue to expand, the global mammalian cell banking market is expected to experience significant growth in the coming years.
This report aims to provide a comprehensive presentation of the global market for Mammalian Cell Banking, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mammalian Cell Banking.
The Mammalian Cell Banking market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Mammalian Cell Banking market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mammalian Cell Banking companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sartorius Stedim BioOutsource Limited.
Charles River Laboratories.
Eurofins DiscoverX Corporation
Merck KGaA
Lonza Group Ltd
ViruSure
Altogen Labs
Abzena Ltd
Northway Biotechpharma
Selexis SA
Thermo Fisher Scientific Inc.
Catalent, Inc.
CellBank Australia
Creative Bioarray
GenScript Biotech Corporation
Segment by Type
CHO Cell
Human Cells
Animal Cells
Others
Segment by Application
Academic & Research Laboratories
Biopharmaceutical Companies
Contract Research Organizations (CROs)
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Mammalian Cell Banking company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Mammalian Cell Banking Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 CHO Cell
1.2.3 Human Cells
1.2.4 Animal Cells
1.2.5 Others
1.3 Market by Application
1.3.1 Global Mammalian Cell Banking Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Academic & Research Laboratories
1.3.3 Biopharmaceutical Companies
1.3.4 Contract Research Organizations (CROs)
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Mammalian Cell Banking Market Perspective (2020-2031)
2.2 Global Mammalian Cell Banking Growth Trends by Region
2.2.1 Global Mammalian Cell Banking Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Mammalian Cell Banking Historic Market Size by Region (2020-2025)
2.2.3 Mammalian Cell Banking Forecasted Market Size by Region (2026-2031)
2.3 Mammalian Cell Banking Market Dynamics
2.3.1 Mammalian Cell Banking Industry Trends
2.3.2 Mammalian Cell Banking Market Drivers
2.3.3 Mammalian Cell Banking Market Challenges
2.3.4 Mammalian Cell Banking Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Mammalian Cell Banking Players by Revenue
3.1.1 Global Top Mammalian Cell Banking Players by Revenue (2020-2025)
3.1.2 Global Mammalian Cell Banking Revenue Market Share by Players (2020-2025)
3.2 Global Mammalian Cell Banking Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Mammalian Cell Banking Revenue
3.4 Global Mammalian Cell Banking Market Concentration Ratio
3.4.1 Global Mammalian Cell Banking Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Mammalian Cell Banking Revenue in 2024
3.5 Global Key Players of Mammalian Cell Banking Head office and Area Served
3.6 Global Key Players of Mammalian Cell Banking, Product and Application
3.7 Global Key Players of Mammalian Cell Banking, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Mammalian Cell Banking Breakdown Data by Type
4.1 Global Mammalian Cell Banking Historic Market Size by Type (2020-2025)
4.2 Global Mammalian Cell Banking Forecasted Market Size by Type (2026-2031)
5 Mammalian Cell Banking Breakdown Data by Application
5.1 Global Mammalian Cell Banking Historic Market Size by Application (2020-2025)
5.2 Global Mammalian Cell Banking Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Mammalian Cell Banking Market Size (2020-2031)
6.2 North America Mammalian Cell Banking Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Mammalian Cell Banking Market Size by Country (2020-2025)
6.4 North America Mammalian Cell Banking Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Mammalian Cell Banking Market Size (2020-2031)
7.2 Europe Mammalian Cell Banking Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Mammalian Cell Banking Market Size by Country (2020-2025)
7.4 Europe Mammalian Cell Banking Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Mammalian Cell Banking Market Size (2020-2031)
8.2 Asia-Pacific Mammalian Cell Banking Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Mammalian Cell Banking Market Size by Region (2020-2025)
8.4 Asia-Pacific Mammalian Cell Banking Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Mammalian Cell Banking Market Size (2020-2031)
9.2 Latin America Mammalian Cell Banking Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Mammalian Cell Banking Market Size by Country (2020-2025)
9.4 Latin America Mammalian Cell Banking Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Mammalian Cell Banking Market Size (2020-2031)
10.2 Middle East & Africa Mammalian Cell Banking Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Mammalian Cell Banking Market Size by Country (2020-2025)
10.4 Middle East & Africa Mammalian Cell Banking Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sartorius Stedim BioOutsource Limited.
11.1.1 Sartorius Stedim BioOutsource Limited. Company Details
11.1.2 Sartorius Stedim BioOutsource Limited. Business Overview
11.1.3 Sartorius Stedim BioOutsource Limited. Mammalian Cell Banking Introduction
11.1.4 Sartorius Stedim BioOutsource Limited. Revenue in Mammalian Cell Banking Business (2020-2025)
11.1.5 Sartorius Stedim BioOutsource Limited. Recent Development
11.2 Charles River Laboratories.
11.2.1 Charles River Laboratories. Company Details
11.2.2 Charles River Laboratories. Business Overview
11.2.3 Charles River Laboratories. Mammalian Cell Banking Introduction
11.2.4 Charles River Laboratories. Revenue in Mammalian Cell Banking Business (2020-2025)
11.2.5 Charles River Laboratories. Recent Development
11.3 Eurofins DiscoverX Corporation
11.3.1 Eurofins DiscoverX Corporation Company Details
11.3.2 Eurofins DiscoverX Corporation Business Overview
11.3.3 Eurofins DiscoverX Corporation Mammalian Cell Banking Introduction
11.3.4 Eurofins DiscoverX Corporation Revenue in Mammalian Cell Banking Business (2020-2025)
11.3.5 Eurofins DiscoverX Corporation Recent Development
11.4 Merck KGaA
11.4.1 Merck KGaA Company Details
11.4.2 Merck KGaA Business Overview
11.4.3 Merck KGaA Mammalian Cell Banking Introduction
11.4.4 Merck KGaA Revenue in Mammalian Cell Banking Business (2020-2025)
11.4.5 Merck KGaA Recent Development
11.5 Lonza Group Ltd
11.5.1 Lonza Group Ltd Company Details
11.5.2 Lonza Group Ltd Business Overview
11.5.3 Lonza Group Ltd Mammalian Cell Banking Introduction
11.5.4 Lonza Group Ltd Revenue in Mammalian Cell Banking Business (2020-2025)
11.5.5 Lonza Group Ltd Recent Development
11.6 ViruSure
11.6.1 ViruSure Company Details
11.6.2 ViruSure Business Overview
11.6.3 ViruSure Mammalian Cell Banking Introduction
11.6.4 ViruSure Revenue in Mammalian Cell Banking Business (2020-2025)
11.6.5 ViruSure Recent Development
11.7 Altogen Labs
11.7.1 Altogen Labs Company Details
11.7.2 Altogen Labs Business Overview
11.7.3 Altogen Labs Mammalian Cell Banking Introduction
11.7.4 Altogen Labs Revenue in Mammalian Cell Banking Business (2020-2025)
11.7.5 Altogen Labs Recent Development
11.8 Abzena Ltd
11.8.1 Abzena Ltd Company Details
11.8.2 Abzena Ltd Business Overview
11.8.3 Abzena Ltd Mammalian Cell Banking Introduction
11.8.4 Abzena Ltd Revenue in Mammalian Cell Banking Business (2020-2025)
11.8.5 Abzena Ltd Recent Development
11.9 Northway Biotechpharma
11.9.1 Northway Biotechpharma Company Details
11.9.2 Northway Biotechpharma Business Overview
11.9.3 Northway Biotechpharma Mammalian Cell Banking Introduction
11.9.4 Northway Biotechpharma Revenue in Mammalian Cell Banking Business (2020-2025)
11.9.5 Northway Biotechpharma Recent Development
11.10 Selexis SA
11.10.1 Selexis SA Company Details
11.10.2 Selexis SA Business Overview
11.10.3 Selexis SA Mammalian Cell Banking Introduction
11.10.4 Selexis SA Revenue in Mammalian Cell Banking Business (2020-2025)
11.10.5 Selexis SA Recent Development
11.11 Thermo Fisher Scientific Inc.
11.11.1 Thermo Fisher Scientific Inc. Company Details
11.11.2 Thermo Fisher Scientific Inc. Business Overview
11.11.3 Thermo Fisher Scientific Inc. Mammalian Cell Banking Introduction
11.11.4 Thermo Fisher Scientific Inc. Revenue in Mammalian Cell Banking Business (2020-2025)
11.11.5 Thermo Fisher Scientific Inc. Recent Development
11.12 Catalent, Inc.
11.12.1 Catalent, Inc. Company Details
11.12.2 Catalent, Inc. Business Overview
11.12.3 Catalent, Inc. Mammalian Cell Banking Introduction
11.12.4 Catalent, Inc. Revenue in Mammalian Cell Banking Business (2020-2025)
11.12.5 Catalent, Inc. Recent Development
11.13 CellBank Australia
11.13.1 CellBank Australia Company Details
11.13.2 CellBank Australia Business Overview
11.13.3 CellBank Australia Mammalian Cell Banking Introduction
11.13.4 CellBank Australia Revenue in Mammalian Cell Banking Business (2020-2025)
11.13.5 CellBank Australia Recent Development
11.14 Creative Bioarray
11.14.1 Creative Bioarray Company Details
11.14.2 Creative Bioarray Business Overview
11.14.3 Creative Bioarray Mammalian Cell Banking Introduction
11.14.4 Creative Bioarray Revenue in Mammalian Cell Banking Business (2020-2025)
11.14.5 Creative Bioarray Recent Development
11.15 GenScript Biotech Corporation
11.15.1 GenScript Biotech Corporation Company Details
11.15.2 GenScript Biotech Corporation Business Overview
11.15.3 GenScript Biotech Corporation Mammalian Cell Banking Introduction
11.15.4 GenScript Biotech Corporation Revenue in Mammalian Cell Banking Business (2020-2025)
11.15.5 GenScript Biotech Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Mammalian Cell Banking Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 CHO Cell
1.2.3 Human Cells
1.2.4 Animal Cells
1.2.5 Others
1.3 Market by Application
1.3.1 Global Mammalian Cell Banking Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Academic & Research Laboratories
1.3.3 Biopharmaceutical Companies
1.3.4 Contract Research Organizations (CROs)
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Mammalian Cell Banking Market Perspective (2020-2031)
2.2 Global Mammalian Cell Banking Growth Trends by Region
2.2.1 Global Mammalian Cell Banking Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Mammalian Cell Banking Historic Market Size by Region (2020-2025)
2.2.3 Mammalian Cell Banking Forecasted Market Size by Region (2026-2031)
2.3 Mammalian Cell Banking Market Dynamics
2.3.1 Mammalian Cell Banking Industry Trends
2.3.2 Mammalian Cell Banking Market Drivers
2.3.3 Mammalian Cell Banking Market Challenges
2.3.4 Mammalian Cell Banking Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Mammalian Cell Banking Players by Revenue
3.1.1 Global Top Mammalian Cell Banking Players by Revenue (2020-2025)
3.1.2 Global Mammalian Cell Banking Revenue Market Share by Players (2020-2025)
3.2 Global Mammalian Cell Banking Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Mammalian Cell Banking Revenue
3.4 Global Mammalian Cell Banking Market Concentration Ratio
3.4.1 Global Mammalian Cell Banking Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Mammalian Cell Banking Revenue in 2024
3.5 Global Key Players of Mammalian Cell Banking Head office and Area Served
3.6 Global Key Players of Mammalian Cell Banking, Product and Application
3.7 Global Key Players of Mammalian Cell Banking, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Mammalian Cell Banking Breakdown Data by Type
4.1 Global Mammalian Cell Banking Historic Market Size by Type (2020-2025)
4.2 Global Mammalian Cell Banking Forecasted Market Size by Type (2026-2031)
5 Mammalian Cell Banking Breakdown Data by Application
5.1 Global Mammalian Cell Banking Historic Market Size by Application (2020-2025)
5.2 Global Mammalian Cell Banking Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Mammalian Cell Banking Market Size (2020-2031)
6.2 North America Mammalian Cell Banking Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Mammalian Cell Banking Market Size by Country (2020-2025)
6.4 North America Mammalian Cell Banking Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Mammalian Cell Banking Market Size (2020-2031)
7.2 Europe Mammalian Cell Banking Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Mammalian Cell Banking Market Size by Country (2020-2025)
7.4 Europe Mammalian Cell Banking Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Mammalian Cell Banking Market Size (2020-2031)
8.2 Asia-Pacific Mammalian Cell Banking Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Mammalian Cell Banking Market Size by Region (2020-2025)
8.4 Asia-Pacific Mammalian Cell Banking Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Mammalian Cell Banking Market Size (2020-2031)
9.2 Latin America Mammalian Cell Banking Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Mammalian Cell Banking Market Size by Country (2020-2025)
9.4 Latin America Mammalian Cell Banking Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Mammalian Cell Banking Market Size (2020-2031)
10.2 Middle East & Africa Mammalian Cell Banking Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Mammalian Cell Banking Market Size by Country (2020-2025)
10.4 Middle East & Africa Mammalian Cell Banking Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sartorius Stedim BioOutsource Limited.
11.1.1 Sartorius Stedim BioOutsource Limited. Company Details
11.1.2 Sartorius Stedim BioOutsource Limited. Business Overview
11.1.3 Sartorius Stedim BioOutsource Limited. Mammalian Cell Banking Introduction
11.1.4 Sartorius Stedim BioOutsource Limited. Revenue in Mammalian Cell Banking Business (2020-2025)
11.1.5 Sartorius Stedim BioOutsource Limited. Recent Development
11.2 Charles River Laboratories.
11.2.1 Charles River Laboratories. Company Details
11.2.2 Charles River Laboratories. Business Overview
11.2.3 Charles River Laboratories. Mammalian Cell Banking Introduction
11.2.4 Charles River Laboratories. Revenue in Mammalian Cell Banking Business (2020-2025)
11.2.5 Charles River Laboratories. Recent Development
11.3 Eurofins DiscoverX Corporation
11.3.1 Eurofins DiscoverX Corporation Company Details
11.3.2 Eurofins DiscoverX Corporation Business Overview
11.3.3 Eurofins DiscoverX Corporation Mammalian Cell Banking Introduction
11.3.4 Eurofins DiscoverX Corporation Revenue in Mammalian Cell Banking Business (2020-2025)
11.3.5 Eurofins DiscoverX Corporation Recent Development
11.4 Merck KGaA
11.4.1 Merck KGaA Company Details
11.4.2 Merck KGaA Business Overview
11.4.3 Merck KGaA Mammalian Cell Banking Introduction
11.4.4 Merck KGaA Revenue in Mammalian Cell Banking Business (2020-2025)
11.4.5 Merck KGaA Recent Development
11.5 Lonza Group Ltd
11.5.1 Lonza Group Ltd Company Details
11.5.2 Lonza Group Ltd Business Overview
11.5.3 Lonza Group Ltd Mammalian Cell Banking Introduction
11.5.4 Lonza Group Ltd Revenue in Mammalian Cell Banking Business (2020-2025)
11.5.5 Lonza Group Ltd Recent Development
11.6 ViruSure
11.6.1 ViruSure Company Details
11.6.2 ViruSure Business Overview
11.6.3 ViruSure Mammalian Cell Banking Introduction
11.6.4 ViruSure Revenue in Mammalian Cell Banking Business (2020-2025)
11.6.5 ViruSure Recent Development
11.7 Altogen Labs
11.7.1 Altogen Labs Company Details
11.7.2 Altogen Labs Business Overview
11.7.3 Altogen Labs Mammalian Cell Banking Introduction
11.7.4 Altogen Labs Revenue in Mammalian Cell Banking Business (2020-2025)
11.7.5 Altogen Labs Recent Development
11.8 Abzena Ltd
11.8.1 Abzena Ltd Company Details
11.8.2 Abzena Ltd Business Overview
11.8.3 Abzena Ltd Mammalian Cell Banking Introduction
11.8.4 Abzena Ltd Revenue in Mammalian Cell Banking Business (2020-2025)
11.8.5 Abzena Ltd Recent Development
11.9 Northway Biotechpharma
11.9.1 Northway Biotechpharma Company Details
11.9.2 Northway Biotechpharma Business Overview
11.9.3 Northway Biotechpharma Mammalian Cell Banking Introduction
11.9.4 Northway Biotechpharma Revenue in Mammalian Cell Banking Business (2020-2025)
11.9.5 Northway Biotechpharma Recent Development
11.10 Selexis SA
11.10.1 Selexis SA Company Details
11.10.2 Selexis SA Business Overview
11.10.3 Selexis SA Mammalian Cell Banking Introduction
11.10.4 Selexis SA Revenue in Mammalian Cell Banking Business (2020-2025)
11.10.5 Selexis SA Recent Development
11.11 Thermo Fisher Scientific Inc.
11.11.1 Thermo Fisher Scientific Inc. Company Details
11.11.2 Thermo Fisher Scientific Inc. Business Overview
11.11.3 Thermo Fisher Scientific Inc. Mammalian Cell Banking Introduction
11.11.4 Thermo Fisher Scientific Inc. Revenue in Mammalian Cell Banking Business (2020-2025)
11.11.5 Thermo Fisher Scientific Inc. Recent Development
11.12 Catalent, Inc.
11.12.1 Catalent, Inc. Company Details
11.12.2 Catalent, Inc. Business Overview
11.12.3 Catalent, Inc. Mammalian Cell Banking Introduction
11.12.4 Catalent, Inc. Revenue in Mammalian Cell Banking Business (2020-2025)
11.12.5 Catalent, Inc. Recent Development
11.13 CellBank Australia
11.13.1 CellBank Australia Company Details
11.13.2 CellBank Australia Business Overview
11.13.3 CellBank Australia Mammalian Cell Banking Introduction
11.13.4 CellBank Australia Revenue in Mammalian Cell Banking Business (2020-2025)
11.13.5 CellBank Australia Recent Development
11.14 Creative Bioarray
11.14.1 Creative Bioarray Company Details
11.14.2 Creative Bioarray Business Overview
11.14.3 Creative Bioarray Mammalian Cell Banking Introduction
11.14.4 Creative Bioarray Revenue in Mammalian Cell Banking Business (2020-2025)
11.14.5 Creative Bioarray Recent Development
11.15 GenScript Biotech Corporation
11.15.1 GenScript Biotech Corporation Company Details
11.15.2 GenScript Biotech Corporation Business Overview
11.15.3 GenScript Biotech Corporation Mammalian Cell Banking Introduction
11.15.4 GenScript Biotech Corporation Revenue in Mammalian Cell Banking Business (2020-2025)
11.15.5 GenScript Biotech Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Mammalian Cell Banking Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of CHO Cell
Table 3. Key Players of Human Cells
Table 4. Key Players of Animal Cells
Table 5. Key Players of Others
Table 6. Global Mammalian Cell Banking Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Mammalian Cell Banking Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Mammalian Cell Banking Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Mammalian Cell Banking Market Share by Region (2020-2025)
Table 10. Global Mammalian Cell Banking Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Mammalian Cell Banking Market Share by Region (2026-2031)
Table 12. Mammalian Cell Banking Market Trends
Table 13. Mammalian Cell Banking Market Drivers
Table 14. Mammalian Cell Banking Market Challenges
Table 15. Mammalian Cell Banking Market Restraints
Table 16. Global Mammalian Cell Banking Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Mammalian Cell Banking Market Share by Players (2020-2025)
Table 18. Global Top Mammalian Cell Banking Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mammalian Cell Banking as of 2024)
Table 19. Ranking of Global Top Mammalian Cell Banking Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Mammalian Cell Banking Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Mammalian Cell Banking, Headquarters and Area Served
Table 22. Global Key Players of Mammalian Cell Banking, Product and Application
Table 23. Global Key Players of Mammalian Cell Banking, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Mammalian Cell Banking Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Mammalian Cell Banking Revenue Market Share by Type (2020-2025)
Table 27. Global Mammalian Cell Banking Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Mammalian Cell Banking Revenue Market Share by Type (2026-2031)
Table 29. Global Mammalian Cell Banking Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Mammalian Cell Banking Revenue Market Share by Application (2020-2025)
Table 31. Global Mammalian Cell Banking Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Mammalian Cell Banking Revenue Market Share by Application (2026-2031)
Table 33. North America Mammalian Cell Banking Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Mammalian Cell Banking Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Mammalian Cell Banking Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Mammalian Cell Banking Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Mammalian Cell Banking Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Mammalian Cell Banking Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Mammalian Cell Banking Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Mammalian Cell Banking Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Mammalian Cell Banking Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Mammalian Cell Banking Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Mammalian Cell Banking Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Mammalian Cell Banking Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Mammalian Cell Banking Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Mammalian Cell Banking Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Mammalian Cell Banking Market Size by Country (2026-2031) & (US$ Million)
Table 48. Sartorius Stedim BioOutsource Limited. Company Details
Table 49. Sartorius Stedim BioOutsource Limited. Business Overview
Table 50. Sartorius Stedim BioOutsource Limited. Mammalian Cell Banking Product
Table 51. Sartorius Stedim BioOutsource Limited. Revenue in Mammalian Cell Banking Business (2020-2025) & (US$ Million)
Table 52. Sartorius Stedim BioOutsource Limited. Recent Development
Table 53. Charles River Laboratories. Company Details
Table 54. Charles River Laboratories. Business Overview
Table 55. Charles River Laboratories. Mammalian Cell Banking Product
Table 56. Charles River Laboratories. Revenue in Mammalian Cell Banking Business (2020-2025) & (US$ Million)
Table 57. Charles River Laboratories. Recent Development
Table 58. Eurofins DiscoverX Corporation Company Details
Table 59. Eurofins DiscoverX Corporation Business Overview
Table 60. Eurofins DiscoverX Corporation Mammalian Cell Banking Product
Table 61. Eurofins DiscoverX Corporation Revenue in Mammalian Cell Banking Business (2020-2025) & (US$ Million)
Table 62. Eurofins DiscoverX Corporation Recent Development
Table 63. Merck KGaA Company Details
Table 64. Merck KGaA Business Overview
Table 65. Merck KGaA Mammalian Cell Banking Product
Table 66. Merck KGaA Revenue in Mammalian Cell Banking Business (2020-2025) & (US$ Million)
Table 67. Merck KGaA Recent Development
Table 68. Lonza Group Ltd Company Details
Table 69. Lonza Group Ltd Business Overview
Table 70. Lonza Group Ltd Mammalian Cell Banking Product
Table 71. Lonza Group Ltd Revenue in Mammalian Cell Banking Business (2020-2025) & (US$ Million)
Table 72. Lonza Group Ltd Recent Development
Table 73. ViruSure Company Details
Table 74. ViruSure Business Overview
Table 75. ViruSure Mammalian Cell Banking Product
Table 76. ViruSure Revenue in Mammalian Cell Banking Business (2020-2025) & (US$ Million)
Table 77. ViruSure Recent Development
Table 78. Altogen Labs Company Details
Table 79. Altogen Labs Business Overview
Table 80. Altogen Labs Mammalian Cell Banking Product
Table 81. Altogen Labs Revenue in Mammalian Cell Banking Business (2020-2025) & (US$ Million)
Table 82. Altogen Labs Recent Development
Table 83. Abzena Ltd Company Details
Table 84. Abzena Ltd Business Overview
Table 85. Abzena Ltd Mammalian Cell Banking Product
Table 86. Abzena Ltd Revenue in Mammalian Cell Banking Business (2020-2025) & (US$ Million)
Table 87. Abzena Ltd Recent Development
Table 88. Northway Biotechpharma Company Details
Table 89. Northway Biotechpharma Business Overview
Table 90. Northway Biotechpharma Mammalian Cell Banking Product
Table 91. Northway Biotechpharma Revenue in Mammalian Cell Banking Business (2020-2025) & (US$ Million)
Table 92. Northway Biotechpharma Recent Development
Table 93. Selexis SA Company Details
Table 94. Selexis SA Business Overview
Table 95. Selexis SA Mammalian Cell Banking Product
Table 96. Selexis SA Revenue in Mammalian Cell Banking Business (2020-2025) & (US$ Million)
Table 97. Selexis SA Recent Development
Table 98. Thermo Fisher Scientific Inc. Company Details
Table 99. Thermo Fisher Scientific Inc. Business Overview
Table 100. Thermo Fisher Scientific Inc. Mammalian Cell Banking Product
Table 101. Thermo Fisher Scientific Inc. Revenue in Mammalian Cell Banking Business (2020-2025) & (US$ Million)
Table 102. Thermo Fisher Scientific Inc. Recent Development
Table 103. Catalent, Inc. Company Details
Table 104. Catalent, Inc. Business Overview
Table 105. Catalent, Inc. Mammalian Cell Banking Product
Table 106. Catalent, Inc. Revenue in Mammalian Cell Banking Business (2020-2025) & (US$ Million)
Table 107. Catalent, Inc. Recent Development
Table 108. CellBank Australia Company Details
Table 109. CellBank Australia Business Overview
Table 110. CellBank Australia Mammalian Cell Banking Product
Table 111. CellBank Australia Revenue in Mammalian Cell Banking Business (2020-2025) & (US$ Million)
Table 112. CellBank Australia Recent Development
Table 113. Creative Bioarray Company Details
Table 114. Creative Bioarray Business Overview
Table 115. Creative Bioarray Mammalian Cell Banking Product
Table 116. Creative Bioarray Revenue in Mammalian Cell Banking Business (2020-2025) & (US$ Million)
Table 117. Creative Bioarray Recent Development
Table 118. GenScript Biotech Corporation Company Details
Table 119. GenScript Biotech Corporation Business Overview
Table 120. GenScript Biotech Corporation Mammalian Cell Banking Product
Table 121. GenScript Biotech Corporation Revenue in Mammalian Cell Banking Business (2020-2025) & (US$ Million)
Table 122. GenScript Biotech Corporation Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Mammalian Cell Banking Picture
Figure 2. Global Mammalian Cell Banking Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Mammalian Cell Banking Market Share by Type: 2024 VS 2031
Figure 4. CHO Cell Features
Figure 5. Human Cells Features
Figure 6. Animal Cells Features
Figure 7. Others Features
Figure 8. Global Mammalian Cell Banking Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Mammalian Cell Banking Market Share by Application: 2024 VS 2031
Figure 10. Academic & Research Laboratories Case Studies
Figure 11. Biopharmaceutical Companies Case Studies
Figure 12. Contract Research Organizations (CROs) Case Studies
Figure 13. Others Case Studies
Figure 14. Mammalian Cell Banking Report Years Considered
Figure 15. Global Mammalian Cell Banking Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Mammalian Cell Banking Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Mammalian Cell Banking Market Share by Region: 2024 VS 2031
Figure 18. Global Mammalian Cell Banking Market Share by Players in 2024
Figure 19. Global Top Mammalian Cell Banking Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mammalian Cell Banking as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Mammalian Cell Banking Revenue in 2024
Figure 21. North America Mammalian Cell Banking Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Mammalian Cell Banking Market Share by Country (2020-2031)
Figure 23. United States Mammalian Cell Banking Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Mammalian Cell Banking Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Mammalian Cell Banking Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Mammalian Cell Banking Market Share by Country (2020-2031)
Figure 27. Germany Mammalian Cell Banking Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Mammalian Cell Banking Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Mammalian Cell Banking Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Mammalian Cell Banking Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Mammalian Cell Banking Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Mammalian Cell Banking Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Mammalian Cell Banking Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Mammalian Cell Banking Market Share by Region (2020-2031)
Figure 35. China Mammalian Cell Banking Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Mammalian Cell Banking Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Mammalian Cell Banking Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Mammalian Cell Banking Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Mammalian Cell Banking Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Mammalian Cell Banking Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Mammalian Cell Banking Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Mammalian Cell Banking Market Share by Country (2020-2031)
Figure 43. Mexico Mammalian Cell Banking Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Mammalian Cell Banking Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Mammalian Cell Banking Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Mammalian Cell Banking Market Share by Country (2020-2031)
Figure 47. Turkey Mammalian Cell Banking Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Mammalian Cell Banking Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Mammalian Cell Banking Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Sartorius Stedim BioOutsource Limited. Revenue Growth Rate in Mammalian Cell Banking Business (2020-2025)
Figure 51. Charles River Laboratories. Revenue Growth Rate in Mammalian Cell Banking Business (2020-2025)
Figure 52. Eurofins DiscoverX Corporation Revenue Growth Rate in Mammalian Cell Banking Business (2020-2025)
Figure 53. Merck KGaA Revenue Growth Rate in Mammalian Cell Banking Business (2020-2025)
Figure 54. Lonza Group Ltd Revenue Growth Rate in Mammalian Cell Banking Business (2020-2025)
Figure 55. ViruSure Revenue Growth Rate in Mammalian Cell Banking Business (2020-2025)
Figure 56. Altogen Labs Revenue Growth Rate in Mammalian Cell Banking Business (2020-2025)
Figure 57. Abzena Ltd Revenue Growth Rate in Mammalian Cell Banking Business (2020-2025)
Figure 58. Northway Biotechpharma Revenue Growth Rate in Mammalian Cell Banking Business (2020-2025)
Figure 59. Selexis SA Revenue Growth Rate in Mammalian Cell Banking Business (2020-2025)
Figure 60. Thermo Fisher Scientific Inc. Revenue Growth Rate in Mammalian Cell Banking Business (2020-2025)
Figure 61. Catalent, Inc. Revenue Growth Rate in Mammalian Cell Banking Business (2020-2025)
Figure 62. CellBank Australia Revenue Growth Rate in Mammalian Cell Banking Business (2020-2025)
Figure 63. Creative Bioarray Revenue Growth Rate in Mammalian Cell Banking Business (2020-2025)
Figure 64. GenScript Biotech Corporation Revenue Growth Rate in Mammalian Cell Banking Business (2020-2025)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Table 1. Global Mammalian Cell Banking Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of CHO Cell
Table 3. Key Players of Human Cells
Table 4. Key Players of Animal Cells
Table 5. Key Players of Others
Table 6. Global Mammalian Cell Banking Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Mammalian Cell Banking Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Mammalian Cell Banking Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Mammalian Cell Banking Market Share by Region (2020-2025)
Table 10. Global Mammalian Cell Banking Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Mammalian Cell Banking Market Share by Region (2026-2031)
Table 12. Mammalian Cell Banking Market Trends
Table 13. Mammalian Cell Banking Market Drivers
Table 14. Mammalian Cell Banking Market Challenges
Table 15. Mammalian Cell Banking Market Restraints
Table 16. Global Mammalian Cell Banking Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Mammalian Cell Banking Market Share by Players (2020-2025)
Table 18. Global Top Mammalian Cell Banking Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mammalian Cell Banking as of 2024)
Table 19. Ranking of Global Top Mammalian Cell Banking Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Mammalian Cell Banking Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Mammalian Cell Banking, Headquarters and Area Served
Table 22. Global Key Players of Mammalian Cell Banking, Product and Application
Table 23. Global Key Players of Mammalian Cell Banking, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Mammalian Cell Banking Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Mammalian Cell Banking Revenue Market Share by Type (2020-2025)
Table 27. Global Mammalian Cell Banking Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Mammalian Cell Banking Revenue Market Share by Type (2026-2031)
Table 29. Global Mammalian Cell Banking Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Mammalian Cell Banking Revenue Market Share by Application (2020-2025)
Table 31. Global Mammalian Cell Banking Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Mammalian Cell Banking Revenue Market Share by Application (2026-2031)
Table 33. North America Mammalian Cell Banking Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Mammalian Cell Banking Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Mammalian Cell Banking Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Mammalian Cell Banking Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Mammalian Cell Banking Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Mammalian Cell Banking Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Mammalian Cell Banking Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Mammalian Cell Banking Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Mammalian Cell Banking Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Mammalian Cell Banking Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Mammalian Cell Banking Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Mammalian Cell Banking Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Mammalian Cell Banking Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Mammalian Cell Banking Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Mammalian Cell Banking Market Size by Country (2026-2031) & (US$ Million)
Table 48. Sartorius Stedim BioOutsource Limited. Company Details
Table 49. Sartorius Stedim BioOutsource Limited. Business Overview
Table 50. Sartorius Stedim BioOutsource Limited. Mammalian Cell Banking Product
Table 51. Sartorius Stedim BioOutsource Limited. Revenue in Mammalian Cell Banking Business (2020-2025) & (US$ Million)
Table 52. Sartorius Stedim BioOutsource Limited. Recent Development
Table 53. Charles River Laboratories. Company Details
Table 54. Charles River Laboratories. Business Overview
Table 55. Charles River Laboratories. Mammalian Cell Banking Product
Table 56. Charles River Laboratories. Revenue in Mammalian Cell Banking Business (2020-2025) & (US$ Million)
Table 57. Charles River Laboratories. Recent Development
Table 58. Eurofins DiscoverX Corporation Company Details
Table 59. Eurofins DiscoverX Corporation Business Overview
Table 60. Eurofins DiscoverX Corporation Mammalian Cell Banking Product
Table 61. Eurofins DiscoverX Corporation Revenue in Mammalian Cell Banking Business (2020-2025) & (US$ Million)
Table 62. Eurofins DiscoverX Corporation Recent Development
Table 63. Merck KGaA Company Details
Table 64. Merck KGaA Business Overview
Table 65. Merck KGaA Mammalian Cell Banking Product
Table 66. Merck KGaA Revenue in Mammalian Cell Banking Business (2020-2025) & (US$ Million)
Table 67. Merck KGaA Recent Development
Table 68. Lonza Group Ltd Company Details
Table 69. Lonza Group Ltd Business Overview
Table 70. Lonza Group Ltd Mammalian Cell Banking Product
Table 71. Lonza Group Ltd Revenue in Mammalian Cell Banking Business (2020-2025) & (US$ Million)
Table 72. Lonza Group Ltd Recent Development
Table 73. ViruSure Company Details
Table 74. ViruSure Business Overview
Table 75. ViruSure Mammalian Cell Banking Product
Table 76. ViruSure Revenue in Mammalian Cell Banking Business (2020-2025) & (US$ Million)
Table 77. ViruSure Recent Development
Table 78. Altogen Labs Company Details
Table 79. Altogen Labs Business Overview
Table 80. Altogen Labs Mammalian Cell Banking Product
Table 81. Altogen Labs Revenue in Mammalian Cell Banking Business (2020-2025) & (US$ Million)
Table 82. Altogen Labs Recent Development
Table 83. Abzena Ltd Company Details
Table 84. Abzena Ltd Business Overview
Table 85. Abzena Ltd Mammalian Cell Banking Product
Table 86. Abzena Ltd Revenue in Mammalian Cell Banking Business (2020-2025) & (US$ Million)
Table 87. Abzena Ltd Recent Development
Table 88. Northway Biotechpharma Company Details
Table 89. Northway Biotechpharma Business Overview
Table 90. Northway Biotechpharma Mammalian Cell Banking Product
Table 91. Northway Biotechpharma Revenue in Mammalian Cell Banking Business (2020-2025) & (US$ Million)
Table 92. Northway Biotechpharma Recent Development
Table 93. Selexis SA Company Details
Table 94. Selexis SA Business Overview
Table 95. Selexis SA Mammalian Cell Banking Product
Table 96. Selexis SA Revenue in Mammalian Cell Banking Business (2020-2025) & (US$ Million)
Table 97. Selexis SA Recent Development
Table 98. Thermo Fisher Scientific Inc. Company Details
Table 99. Thermo Fisher Scientific Inc. Business Overview
Table 100. Thermo Fisher Scientific Inc. Mammalian Cell Banking Product
Table 101. Thermo Fisher Scientific Inc. Revenue in Mammalian Cell Banking Business (2020-2025) & (US$ Million)
Table 102. Thermo Fisher Scientific Inc. Recent Development
Table 103. Catalent, Inc. Company Details
Table 104. Catalent, Inc. Business Overview
Table 105. Catalent, Inc. Mammalian Cell Banking Product
Table 106. Catalent, Inc. Revenue in Mammalian Cell Banking Business (2020-2025) & (US$ Million)
Table 107. Catalent, Inc. Recent Development
Table 108. CellBank Australia Company Details
Table 109. CellBank Australia Business Overview
Table 110. CellBank Australia Mammalian Cell Banking Product
Table 111. CellBank Australia Revenue in Mammalian Cell Banking Business (2020-2025) & (US$ Million)
Table 112. CellBank Australia Recent Development
Table 113. Creative Bioarray Company Details
Table 114. Creative Bioarray Business Overview
Table 115. Creative Bioarray Mammalian Cell Banking Product
Table 116. Creative Bioarray Revenue in Mammalian Cell Banking Business (2020-2025) & (US$ Million)
Table 117. Creative Bioarray Recent Development
Table 118. GenScript Biotech Corporation Company Details
Table 119. GenScript Biotech Corporation Business Overview
Table 120. GenScript Biotech Corporation Mammalian Cell Banking Product
Table 121. GenScript Biotech Corporation Revenue in Mammalian Cell Banking Business (2020-2025) & (US$ Million)
Table 122. GenScript Biotech Corporation Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Mammalian Cell Banking Picture
Figure 2. Global Mammalian Cell Banking Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Mammalian Cell Banking Market Share by Type: 2024 VS 2031
Figure 4. CHO Cell Features
Figure 5. Human Cells Features
Figure 6. Animal Cells Features
Figure 7. Others Features
Figure 8. Global Mammalian Cell Banking Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Mammalian Cell Banking Market Share by Application: 2024 VS 2031
Figure 10. Academic & Research Laboratories Case Studies
Figure 11. Biopharmaceutical Companies Case Studies
Figure 12. Contract Research Organizations (CROs) Case Studies
Figure 13. Others Case Studies
Figure 14. Mammalian Cell Banking Report Years Considered
Figure 15. Global Mammalian Cell Banking Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Mammalian Cell Banking Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Mammalian Cell Banking Market Share by Region: 2024 VS 2031
Figure 18. Global Mammalian Cell Banking Market Share by Players in 2024
Figure 19. Global Top Mammalian Cell Banking Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mammalian Cell Banking as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Mammalian Cell Banking Revenue in 2024
Figure 21. North America Mammalian Cell Banking Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Mammalian Cell Banking Market Share by Country (2020-2031)
Figure 23. United States Mammalian Cell Banking Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Mammalian Cell Banking Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Mammalian Cell Banking Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Mammalian Cell Banking Market Share by Country (2020-2031)
Figure 27. Germany Mammalian Cell Banking Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Mammalian Cell Banking Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Mammalian Cell Banking Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Mammalian Cell Banking Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Mammalian Cell Banking Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Mammalian Cell Banking Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Mammalian Cell Banking Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Mammalian Cell Banking Market Share by Region (2020-2031)
Figure 35. China Mammalian Cell Banking Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Mammalian Cell Banking Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Mammalian Cell Banking Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Mammalian Cell Banking Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Mammalian Cell Banking Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Mammalian Cell Banking Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Mammalian Cell Banking Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Mammalian Cell Banking Market Share by Country (2020-2031)
Figure 43. Mexico Mammalian Cell Banking Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Mammalian Cell Banking Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Mammalian Cell Banking Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Mammalian Cell Banking Market Share by Country (2020-2031)
Figure 47. Turkey Mammalian Cell Banking Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Mammalian Cell Banking Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Mammalian Cell Banking Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Sartorius Stedim BioOutsource Limited. Revenue Growth Rate in Mammalian Cell Banking Business (2020-2025)
Figure 51. Charles River Laboratories. Revenue Growth Rate in Mammalian Cell Banking Business (2020-2025)
Figure 52. Eurofins DiscoverX Corporation Revenue Growth Rate in Mammalian Cell Banking Business (2020-2025)
Figure 53. Merck KGaA Revenue Growth Rate in Mammalian Cell Banking Business (2020-2025)
Figure 54. Lonza Group Ltd Revenue Growth Rate in Mammalian Cell Banking Business (2020-2025)
Figure 55. ViruSure Revenue Growth Rate in Mammalian Cell Banking Business (2020-2025)
Figure 56. Altogen Labs Revenue Growth Rate in Mammalian Cell Banking Business (2020-2025)
Figure 57. Abzena Ltd Revenue Growth Rate in Mammalian Cell Banking Business (2020-2025)
Figure 58. Northway Biotechpharma Revenue Growth Rate in Mammalian Cell Banking Business (2020-2025)
Figure 59. Selexis SA Revenue Growth Rate in Mammalian Cell Banking Business (2020-2025)
Figure 60. Thermo Fisher Scientific Inc. Revenue Growth Rate in Mammalian Cell Banking Business (2020-2025)
Figure 61. Catalent, Inc. Revenue Growth Rate in Mammalian Cell Banking Business (2020-2025)
Figure 62. CellBank Australia Revenue Growth Rate in Mammalian Cell Banking Business (2020-2025)
Figure 63. Creative Bioarray Revenue Growth Rate in Mammalian Cell Banking Business (2020-2025)
Figure 64. GenScript Biotech Corporation Revenue Growth Rate in Mammalian Cell Banking Business (2020-2025)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Food Grade FIBC Bulk Bags Market Research Report 2025
Jan 09, 25
Global Standard FIBC Market Research Report 2025
Jan 09, 25
Global Mammoplasty Retractors Market Research Report 2025
Jan 09, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232